Navigation Links
Clearwater's Canadian at-Home Dizziness Treatment Device Cleared by FDA
Date:9/23/2008

The U.S. Food and Drug Administration has cleared DizzyFIX, an at-home treatment for vertigo and dizziness which helps guide patients through the Epley maneuver, for sale in the U.S.

Calgary, Canada (PRWEB) September 23, 2008 -- The U.S. Food and Drug Administration has cleared DizzyFIX, an at-home http://www.dizzyfix.com/what_is_vertigo.asp [treatment for vertigo] and dizziness which helps guide patients through the Epley maneuver, for sale in the U.S.

"DizzyFIX will now be available by prescription in the U.S. and is already available over-the-counter in Canada and other countries," said Dr. Alp Sener, MD, PhD. "Benign Paroxysmal Positional Vertigo (BPPV) is one of the leading causes of dizziness. Dizziness from BPPV affects as many as 10 per cent of people over age 60."

The FDA ruling followed an extensive review by the U.S. agency of peer-reviewed research demonstrating the effectiveness of the DizzyFIX in http://www.dizzyfix.com/bppv_treatments.asp [treatment of BPPV].

Developed by ear, nose and throat specialists, the DizzyFIX is a low-cost, patent-pending dynamic visual-feedback device that easily attaches to a hat. It is used as a guide to the http://www.dizzyfix.com [Epley maneuvers] (particle repositioning maneuvers) that treat the most common cause of vertigo, BPPV.

As many as one in ten people over the age of 60 will suffer from the sudden spinning attacks that characterize BPPV, which can cause nausea, falls and long-term disability.

"Patients who suffer from vertigo now have an alternative to simply masking the symptoms with drug therapy," says Dr. Matthew Bromwich, DizzyFIX inventor and ear, nose and throat specialist. "DizzyFIX enables patients to treat and cure their own symptoms from the comfort of their own home."

The Makers of DizzyFIX
Clearwater Clinical Limited is an innovative Canadian company whose partners met during their education and are either in training or have recently completed training as specialist physicians and surgeons, clinical and basic scientists, computer specialists and businessmen.

Their primary objective is to foster the development of novel concepts in medical technology and introduce them into the marketplace. The team is geographically diverse and teleconferences from six cities in three countries.

To learn more about the DizzyFIX, please visit DizzyFIX.com or see our site for background information on DizzyFIX and more information about the Epley Maneuver. http://www.dizzyfix.com/dizzyfix.asp

Contact:
Dr. Jacob Jaremko
Clearwater Clinical Limited, makers of the DizzyFIX
www.clearwaterclinical.com
1-877-349-9934

# # #

Read the full story at http://www.prweb.com/releases/vertigo_treatment/DizzyFIX/prweb1369694.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Ibuprofen can slow lung disease in children with cystic fibrosis, Canadian study shows
3. New Canadian study finds drug coated heart stents to be safe:
4. Canadians welcome HPV vaccine -- but not at any price
5. Mayo Clinic Calls for Thorough Review of Canadian Pacifics Acquisition of the Dakota, Minnesota & Eastern Railroad
6. Canadian Pacific and Mayo Clinic Build Understanding and Commit to Ongoing Dialogue
7. Map the Canadian Healthcare IT Market with the New HIMSS Analytics Canadian Database(SM)
8. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
9. Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger
10. Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study
11. Leading Travel Insurance Website Now Offers Mexican Auto Insurance to US and Canadian Travelers Going into Mexico
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Clearwater's Canadian at-Home Dizziness Treatment Device Cleared by FDA 
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
(Date:6/23/2016)... ITASCA, Ill. , June 23, 2016  In a startling ... states are failing their residents by lacking a comprehensive, proven plan ... , a definitive ranking of how states are tackling the ... rating to only four states – Kentucky , ... and Vermont . Of the 28 failing states, ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
Breaking Medicine Technology: